LPOXY Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 2

  • Investments
  • 1

LPOXY Therapeutics General Information

Description

Developer of orally administered intestinal oxygen delivery therapy intended to prevent antibiotic-induced superinfections. The company offers capsules that deliver oxygen directly to the bowel, enabling patients to develop targeted therapies.

Contact Information

Website
www.lpoxy.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Platte City, MO
  • United States
+1 (816)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Platte City, MO
  • United States
+1 (816)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LPOXY Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LPOXY Therapeutics‘s full profile, request access.

Request a free trial

LPOXY Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of orally administered intestinal oxygen delivery therapy intended to prevent antibiotic-induced superinfectio
Drug Discovery
Platte City, MO

Rockville, MD
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

LPOXY Therapeutics Competitors (2)

One of LPOXY Therapeutics’s 2 competitors is Theriva Biologics, a Corporation company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Theriva Biologics Corporation Rockville, MD
Pfizer Corporation New York, NY
You’re viewing 2 of 2 competitors. Get the full list »

LPOXY Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LPOXY Therapeutics‘s full profile, request access.

Request a free trial

LPOXY Therapeutics Investments (1)

LPOXY Therapeutics’s most recent deal was a Corporate Asset Purchase with Xeno Biosciences (Selected Assets in Cambridge, Massachusetts) for . The deal was made on 15-Jan-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Xeno Biosciences (Selected Assets in Cambridge, Massachusetts) 15-Jan-2025 Corporate Asset Purchase Buildings and Property
To view LPOXY Therapeutics’s complete investments history, request access »

LPOXY Therapeutics FAQs

  • When was LPOXY Therapeutics founded?

    LPOXY Therapeutics was founded in 2020.

  • Where is LPOXY Therapeutics headquartered?

    LPOXY Therapeutics is headquartered in Platte City, MO.

  • What industry is LPOXY Therapeutics in?

    LPOXY Therapeutics’s primary industry is Drug Discovery.

  • Is LPOXY Therapeutics a private or public company?

    LPOXY Therapeutics is a Private company.

  • What is LPOXY Therapeutics’s current revenue?

    The current revenue for LPOXY Therapeutics is .

  • How much funding has LPOXY Therapeutics raised over time?

    LPOXY Therapeutics has raised $29.2M.

  • Who are LPOXY Therapeutics’s investors?

    5 Horizons Capital has invested in LPOXY Therapeutics.

  • Who are LPOXY Therapeutics’s competitors?

    Theriva Biologics and Pfizer are competitors of LPOXY Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process